Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase inhibitor (NTBC)
- 1 March 1996
- journal article
- case report
- Published by Springer Nature in Journal of Inherited Metabolic Disease
- Vol. 19 (2) , 234-238
- https://doi.org/10.1007/bf01799438
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The Nephropathy of Type I Tyrosinemia after Liver TransplantationPediatric Research, 1995
- Hereditary tyrosinemia type I: a new clinical classification with difference in prognosis on dietary treatment.1994
- Hereditary Tyrosinemia Type I: A New Clinical Classification With Difference in Prognosis on Dietary TreatmentHepatology, 1994
- Peripheral neuropathy as the presenting feature of tyrosinaemia type I and effectively treated with an inhibitor of 4-hydroxyphenylpyruvate dioxygenase.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenaseThe Lancet, 1992
- Rapid Improvement in the Renal Tubular Dysfunction Associated With Tyrosinemia Following Hepatic ReplacementPediatrics, 1992
- Renal failure in adult patients with hereditary tyrosinaemia type IJournal of Inherited Metabolic Disease, 1990
- Contribution of extrahepatic tissues to biochemical abnormalities in hereditary tyrosinemia type I: Study of three patients after liver transplantationThe Journal of Pediatrics, 1987
- Renal Bicarbonate Reabsorption and Hydrogen Ion Excretion in Normal Infants*Journal of Clinical Investigation, 1967